CRSP Earnings:
* Mon 9-NOV-2026
End of day quotes updated Fri Aug 21 15:50 CST
🏠
🔍
21-Aug-2026
59.50
+1.38 {+2.4 %}
V: 2,448,282
CRSP
21-Aug-2026
Close: 59.50
+1.38 {+2.4 %}
Volume: 2,448,282
24-Jul-2026
29-May-2026
30-Sep-2025
31-Mar-2023
CRSP
SPY
2.4
11.1
24.0
9.1
13.5
0.4
-1.4
2.5
2.5
12.3
% Price Gain
WTD Performance (%)
MTD Performance (%)
QTD Performance (%)
YTD Performance (%)
SPY tracks S&P 500 index.
15 minute intraday candlestick chart, ~15 minute delay
15 minute intraday candlestick chart, ~15 minute delay
CRSP News
3-Aug-2026 - Yahoo FinanceCRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Tops Revenue Estimates CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of +14.55% and +37.28%, respectively, for the quarter ... 27-Jul-2026 - Yahoo FinanceCRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher? CRISPR Therapeutics (CRSP) possesses the right combination of the two key ingredients for a likely earnings beat in its ... 22-Jul-2026 - The Globe and MailCrispr Therapeutics AG (CRSP) Receives a Hold from Goldman Sachs In a report released yesterday, from Goldman Sachs maintained a Hold rating on Crispr Therapeutics AG, with a price target of $48.00. The company’s shares closed today at $46.99. Unlock powerful ... 20-Jul-2026 - Seeking AlphaCrispr Therapeutics: A Catalyst-Rich 12 Months Ahead CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead asset and multiple upcoming ... 17-Jul-2026 - Yahoo FinanceCRISPR Therapeutics (CRSP) Slides For Six Days, Is The Stock Now Cheap? CRISPR Therapeutics (NasdaqGM:CRSP) has come under pressure after a six day losing streak that cut the stock by about 18%, ... 7-Jul-2026 - Yahoo FinanceCRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026? One has FDA approval and revenue; the other is pre-commercial but debt-free. Both face distinct risks that could reshape your ... 5-Jul-2026 - Yahoo FinanceCRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? One company leads in gene-editing approvals, while the other targets surging demand in metabolic treatments. Here’s how their ... 3-Jul-2026 - Yahoo FinanceCRISPR Therapeutics (CRSP) Stock Looks Stretched On Book Value Yet Reasonable On Broader Checks CRISPR Therapeutics stock has rebounded in the short term; however, over five years the share price is still significantly ... 30-Jun-2026 - Zacks Investment ResearchInvestors heavily search CRISPR Therapeutics AG (CRSP): Here is what you need to know CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
More CRSP News
Disclaimer
Privacy
Contact
Copyright © 2001-2026, All rights reserved. HotCandlestick.com, LLC